undamentalytics Newsletter

Coliseum Capital, LLC: insider trades

Director, 10% owner at 6 companies we cover. 13 open-market purchases and 3 sales not made under a pre-set plan, reported from January 11, 2016 to August 5, 2025.

Would copying Coliseum Capital, LLC’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 9 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on December 29, 2021 into $2,214 by November 2, 2026, −26.9% a year. The copy held shares only 88% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $16,941, +11.6% a year (the S&P 500 held throughout made $16,880, +11.5% a year). Beta against the index was 1.60. Twelve months after each report, the average purchase was −32.8% against the S&P 500 (median −33.1%), and 22% beat it. Measured from the trade date, the insider’s own timing, the average was −31.8%. After their sales, the shares moved −14.1% against the index over 12 months on average (a negative figure means selling was the right call); 67% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 202120222023202420252026 $16.9k$16.9k$2.2k
Copying Coliseum Capital, LLCS&P 500, same days investedS&P 500, held throughout $10,000 copying Coliseum Capital, LLC’s open-market purchases from December 29, 2021, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−26.9%
S&P 500, same days invested
+11.6% (held throughout +11.5%)
Time in shares
88%
Sharpe ratio (S&P 500)
−0.20 (0.48)
Biggest drop (S&P 500)
−83% (−25%)
Market sensitivity (beta)
1.60
Purchases copied
9

Trade by trade

Coliseum Capital, LLC: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 9 −7.9% −9.9% 22% 5 −1.35 0.25 No reliable evidence
Purchases, 6 months after the report 9 −18.4% −16.9% 22% 5 −2.46 0.070 No reliable evidence
Purchases, 12 months after the report 9 −32.8% −33.1% 22% 5 −6.52 0.003 Some evidence: behind
Purchases, 12 months after the trade 8 −31.8% −38.3% 25% 4 −3.55 0.038 Some evidence: behind
Sales, 3 months after the report 3 −10.9% −16.8% 67% 2 — — Not enough years
Sales, 12 months after the report 3 −14.1% −10.7% 67% 2 — — Not enough years
Sales, 12 months after the trade 3 −15.3% −12.4% 67% 2 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Mastercraft Boat Holdings, Inc. MCFT —41February 10, 2023May 10, 2024
Purple Innovation, Inc. PRPL —40December 28, 2021February 14, 2023
Universal Technical Institute Inc UTI —12January 11, 2016May 14, 2025
Sonos Inc SONO —20July 29, 2025August 5, 2025
Option Care Health, Inc. OPCH —10June 22, 2016June 22, 2016
Accendra Health Inc ACH —10April 10, 2025April 10, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 5, 2025August 1, 2025 SONO Purchase $2,591,345 +41.6%+18.1%+33.1%
July 29, 2025July 25, 2025 SONO Purchase $14,803,883 +43.2%+9.5%+31.8%
May 14, 2025May 12, 2025 UTI Sale $63,576,630 −32.1%−10.7%−12.4%
April 10, 2025April 8, 2025 ACH Purchase $3,073,750 −4.3%−86.9%−102.3%
March 28, 2025March 27, 2025 UTI Sale $25,350,000 +16.3%+25.1%+26.9%
May 10, 2024May 8, 2024 MCFT Purchase $3,185,114 −9.9%−28.7%−24.4%
April 22, 2024April 18, 2024 MCFT Purchase $2,784,069 −16.5%−33.1%−29.7%
March 18, 2024March 15, 2023 MCFT Purchase $3,250,907 −18.9%−32.5%−65.5%
September 28, 2023September 26, 2023 MCFT Purchase $6,058,763 −9.7%−53.7%−50.7%
February 14, 2023February 13, 2023 PRPL Purchase $26,821,440 not yetnot yetnot yet
February 10, 2023February 8, 2023 MCFT Sale $11,487,520 −16.8%−56.7%−60.6%
May 20, 2022May 19, 2022 PRPL Purchase $3,775,360 −48.5%−41.7%not yet
May 18, 2022May 16, 2022 PRPL Purchase $15,632,797 not yetnot yetnot yet
December 28, 2021December 23, 2021 PRPL Purchase $8,155,371 −47.9%−45.9%−46.9%
June 22, 2016June 22, 2016 OPCH Purchase $8,400,000 not yetnot yetnot yet
January 11, 2016January 7, 2016 UTI Purchase $1,688,850 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Coliseum Capital, LLC traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.